January 12, 2023 -
The FDA has approved a label update for Rybelsus (semaglutide) tablets 7 mg or 14 mg, allowing use as a first-line treatment option for adults
Jan. 3, 2023 --
Prophylactic use of methylprednisolone does not reduce the likelihood of a worse
outcome for infants undergoing surgery with cardiopulmonary bypass
Jan. 3, 2023 -
For patients receiving thiazide diuretics, the occurrence of major cardiovascular outcome
events or non-cancer-related deaths is no lower